Gossamer Bio, Inc. - Common Stock (GOSS)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
227,306,614
Total 13F shares
55,807,335
Share change
+3,834,270
Total reported value
$630,887,263
Put/Call ratio
142%
Price per share
$11.31
Number of holders
126
Value change
+$43,005,682
Number of buys
53
Number of sells
54

Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2021

As of 31 Dec 2021, Gossamer Bio, Inc. - Common Stock (GOSS) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,807,335 shares. The largest 10 holders included HHLR ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Omega Fund Management, LLC, BOXER CAPITAL, LLC, Artal Group S.A., CITADEL ADVISORS LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and Palo Alto Investors LP. This page lists 127 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.